Patent Issued for Composition Containing Carboplatin And Use (USPTO 10,980,768)

摘要

2021 MAY 05 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily- A patent by the inventor Liu, Xiaozhong (Potomac, MD), filed on June 20, 2016, was published online on May 3, 2021, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 10,980,768 is assigned to Syn-Nat Products Enterprise LLC (Edison, New Jersey, United States). The following quote was obtained by the news editors from the background information supplied by the inventors: "Leukemia, renal adenocarcinoma and melanoma are malignant cancers that claim hundreds of thousands of lives around the world every year. Researchers have been constantly pursuing new, safe and effective drugs and treatments. "Leukemia is a group of cancers that usually start in blood-forming tissues, such as the bone marrow, and cause a large number of abnormal blood cells to be produced and enter the bloodstream. The major types of leukemia at least include: acute or chronic myelogeneous leukemia, which involves the myeloid elements of bone marrow (white cells, red cells, megakaryocytes), and acute lymphoblastic leukemia (ALL) and chronic lymphocyclic leukemia (CLL), which involve the cells of the lymphoid lineage. More than 50 commercial drugs have been approved by the Food and Drug Administration (FDA) for different types of leukemia. In addition to single drug treatments, the combination of multiple drugs has been widely used. However, leukemia is very complex, and the selection of drugs depends on the types of leukemia. Additional drugs and treatments are still highly desirable.